Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch study comparing two fixed-dose antiretroviral combinations in virologically suppressed HIV-1 patients
PACTR201210000439384Unknown
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of efavirenz and rilpivirine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Number of participants with plasma HIV-1 less than 400 copies per mL. Status: unknown.
02
Drugs
efavirenzrilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR201210000439384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201210000439384.